{
    "article_id": "PMC6246927",
    "article_text_type": "fulltext",
    "article_filtered_sentences": [
        "Part 2 included substudy 1 (patients with high systemic inflammation, ie, Creactive protein [ CRP] >10mg/L) and substudy 2 (patients with low systemic inflammation, ie,  CRP 10mg/L); the primary endpoint was overall survival ( OS).",
        "2.5\n\nMETHODS - Assessments\nThe primary objective of part 1 was to determine safe and tolerable doses of ruxolitinib and regorafenib when administered in combination, with safety and tolerability being the primary endpoint.",
        "The primary objective of part 2 was to evaluate and compare overall survival (OS; primary endpoint; defined as time from randomization to death due to any cause) between the ruxolitinib and placebo groups.",
        "Sample size estimation for part 2 was based on the primary endpoint of OS.",
        "3.2.2\n\nRESULTS - Part 2 - Efficacy\nNo statistically significant difference was observed between treatment groups of substudies 1 or 2 for the primary endpoint of OS (Figure \n           3A,B)."
    ],
    "registry_id": "NCT02119676",
    "registry_primary_outcomes": [
        "Part 1: Determination of the dose of ruxolitinib that is safe and tolerable in combination with regorafenib as measured by the number of dose-limiting toxicities (DLTs) observed in the evaluation cohort , Baseline through Day 28",
        "Part 2: Overall Survival (OS) , Randomization until death due to any cause. Approximately 28 months."
    ],
    "labels": {
        "POS_identif_possible": "No",
        "PO_switch": "",
        "PO_not_reported_registry": "",
        "PO_not_reported_publication": "",
        "POS_timeframe_metric": "",
        "Description": ""
    },
    "article_bio_outcomes": [
        {
            "sentence_nb": 2,
            "tokens": [
                "The",
                "primary",
                "objective",
                "of",
                "part",
                "2",
                "was",
                "to",
                "evaluate",
                "and",
                "compare",
                "overall",
                "survival",
                "(",
                "OS",
                ";",
                "primary",
                "endpoint",
                ";",
                "defined",
                "as",
                "time",
                "from",
                "randomization",
                "to",
                "death",
                "due",
                "to",
                "any",
                "cause",
                ")",
                "between",
                "the",
                "ruxolitinib",
                "and",
                "placebo",
                "groups",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O"
            ]
        },
        {
            "sentence_nb": 0,
            "tokens": [
                "Part",
                "2",
                "included",
                "substudy",
                "1",
                "(",
                "patients",
                "with",
                "high",
                "systemic",
                "inflammation",
                ",",
                "ie",
                ",",
                "Creactive",
                "protein",
                "[",
                "CRP",
                "]",
                ">",
                "10mg",
                "/",
                "L",
                ")",
                "and",
                "substudy",
                "2",
                "(",
                "patients",
                "with",
                "low",
                "systemic",
                "inflammation",
                ",",
                "ie",
                ",",
                "CRP",
                "10mg",
                "/",
                "L",
                ")",
                ";",
                "the",
                "primary",
                "endpoint",
                "was",
                "overall",
                "survival",
                "(",
                "OS",
                ")",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O"
            ]
        },
        {
            "sentence_nb": 1,
            "tokens": [
                "2.5",
                "METHODS",
                "-",
                "Assessments",
                "The",
                "primary",
                "objective",
                "of",
                "part",
                "1",
                "was",
                "to",
                "determine",
                "safe",
                "and",
                "tolerable",
                "doses",
                "of",
                "ruxolitinib",
                "and",
                "regorafenib",
                "when",
                "administered",
                "in",
                "combination",
                ",",
                "with",
                "safety",
                "and",
                "tolerability",
                "being",
                "the",
                "primary",
                "endpoint",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O",
                "O",
                "O",
                "O",
                "O"
            ]
        },
        {
            "sentence_nb": 3,
            "tokens": [
                "Sample",
                "size",
                "estimation",
                "for",
                "part",
                "2",
                "was",
                "based",
                "on",
                "the",
                "primary",
                "endpoint",
                "of",
                "OS",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "O"
            ]
        },
        {
            "sentence_nb": 4,
            "tokens": [
                "3.2.2",
                "RESULTS",
                "-",
                "Part",
                "2",
                "-",
                "Efficacy",
                "No",
                "statistically",
                "significant",
                "difference",
                "was",
                "observed",
                "between",
                "treatment",
                "groups",
                "of",
                "substudies",
                "1",
                "or",
                "2",
                "for",
                "the",
                "primary",
                "endpoint",
                "of",
                "OS",
                "(",
                "Figure",
                "3A",
                ",",
                "B",
                ")",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O"
            ]
        }
    ],
    "article_outcomes_text": [
        "safety and tolerability",
        "OS",
        "overall survival ( OS ; primary endpoint ; defined as time from randomization to death due to any cause )",
        "overall survival ( OS )"
    ],
    "article2article_connections": [
        [
            0,
            1,
            false
        ],
        [
            0,
            2,
            false
        ],
        [
            0,
            3,
            false
        ],
        [
            1,
            2,
            true
        ],
        [
            1,
            3,
            true
        ],
        [
            2,
            3,
            true
        ]
    ],
    "filtered_article_outcomes": [
        "safety and tolerability",
        "overall survival ( OS ; primary endpoint ; defined as time from randomization to death due to any cause )"
    ],
    "article2registry_connections": [
        {
            "article_index": 0,
            "registry_index": 0,
            "similar": true
        },
        {
            "article_index": 0,
            "registry_index": 1,
            "similar": false
        },
        {
            "article_index": 1,
            "registry_index": 0,
            "similar": false
        },
        {
            "article_index": 1,
            "registry_index": 1,
            "similar": true
        }
    ]
}